4//SEC Filing
LINK WILLIAM J PHD 4
Accession 0000950170-24-097097
CIK 0001819790other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:34 PM ET
Size
12.5 KB
Accession
0000950170-24-097097
Insider Transaction Report
Form 4
LINK WILLIAM J PHD
Director
Transactions
- Sale
Common Stock
2024-08-12$26.53/sh−5,021$133,207→ 0 total(indirect: By LLC) - Other
Common Stock
2024-08-12+10,446→ 10,446 total(indirect: By Link Family Enterprise, LP) - Other
Common Stock
2024-08-12+27,116→ 167,098 total - Other
Common Stock
2024-08-12−74,892→ 35,000 total(indirect: By LLC) - Sale
Common Stock
2024-08-12$26.01/sh−29,979$779,754→ 5,021 total(indirect: By LLC)
Footnotes (5)
- [F1]Represents an in-kind pro-rata distribution, and not a purchase or sale, without additional consideration by Flying L Partners XI, LLC to its partners.
- [F2]The shares are held directly held by Flying L Partners XI, LLC. The Reporting Person is the manager of Flying L Partners XI, LLC and may be deemed to have sole voting and investment power over the shares. The Reporting Person disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- [F3]The Reporting Person may be deemed to beneficially own the shares indirectly by reason of the Reporting Person as the controlling member of Link Family Enterprise, LP.
- [F4]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $25.42 to $26.41. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $26.42 to $26.69. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001228684
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:34 PM ET
- Size
- 12.5 KB